Developer docs
API playgroundTry for free, no card

Search company profiles

Instituto Oncoguia

Full company profile

uuid000trdq

Namestring
Instituto Oncoguia
Legal namestring
Instituto Oncoguia
Websiteurl
oncoguia.org.br
Company typeenum
Private
Founded yearint
2003
Descriptiontext

Instituto Oncoguia is a Brazilian non-profit civil association (associação civil sem fins lucrativos) founded in 2003 as Portal Oncoguia by psycho-oncologist Luciana Holtz de Camargo Barros in São Paulo, and officially incorporated as an NGO in 2009. The organization's mission is to combat cancer misinformation and provide evidence-based information, support, advocacy, and treatment access guidance to cancer patients, families, and caregivers across Brazil. It holds OSCIP certification and operates as a national reference institution for cancer patient information.

The organization delivers its services through a multichannel digital platform comprising the Portal Oncoguia web portal, free 0800 telephone hotline (Ligue Câncer), WhatsApp support, email guidance, TV Oncoguia YouTube channel, Podcast Oncoguia, and in-person patient events (OncoDebates, patient encounters). Core products include Radar do Câncer (a data monitoring platform tracking cancer statistics using SUS/DATASUS/INCA/Globocan data), Atlas CCC (geographic mapping of cancer care centers), Pesquisa Clínica (clinical trial information panel), and educational programs like PAR (Paciente Ativo e Responsável) and the Programa Nacional de Apoio ao Paciente com Câncer. Content covers 60+ cancer types and is verified by a Scientific Committee.

Instituto Oncoguia operates on a free-to-patient model with no charges for any services. Revenue is generated through pharmaceutical industry grants and sponsorships (from 20+ companies including Roche, AstraZeneca, Novartis, Pfizer, Bristol Myers Squibb Foundation, GSK, MSD, Lilly, and Johnson & Johnson), individual donations via the "Doe Agora" program, and pro bono institutional partnerships (Canva, Techsoup, Nexxt). The organization is a member of 14 international and national cancer coalitions including UICC, IKCC, World Ovarian Cancer Coalition, and Global Lung Cancer Coalition, and maintains editorial independence through a published Code of Conduct governing pharmaceutical relationships.

Short descriptiontext

Instituto Oncoguia is a Brazilian non-profit NGO that provides free, evidence-based cancer information, patient support, advocacy, and clinical trial access to cancer patients, families, and caregivers across Brazil via a multichannel digital platform and national events.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSão Paulo, Brazil
HQ citystring
São Paulo
HQ countrystring
Brazil
HQ regionstring
Latin America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cancer patient education, patient advocacy services, clinical trial information, patient rights navigation, cancer helpline support
Industry2 codes
PRIMARYHLAJAKAN
Global Health Research, Evidence & Technical Assistance Organizations
Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health & Development Agencies (NGOs/Multilaterals)
SECONDARYHLALAFAD
Oncology Remote Symptom Monitoring & Care Navigation
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
NAICS code3 codes
  • Individual and Family Services6241
  • Other Individual and Family Services62419
  • Educational Support Services611710
SIC code3 codes
  • Services-Membership Organizations8600
  • Services-Health Services8000
  • Services-Educational Services8200
Product category
Patient Advocacy and Cancer Support Services
Revenue model3 records
1Pharmaceutical Industry Grants and Sponsorship
TypeProfessional Services
Description

Instituto Oncoguia receives funding from pharmaceutical companies including Roche, AstraZeneca, Novartis, Pfizer, Bristol Myers Squibb Foundation, and 20+ other pharmaceutical companies for project financing, event sponsorship, and institutional support

oncoguia.org.br
2Individual Donations
TypeAffiliate Referral
Description

Individual donations from supporters who contribute to the organization's mission through the 'Doe Agora' (Donate Now) program

oncoguia.org.br
3Institutional Partnerships
TypeLicensing Royalties
Description

Partnerships with companies providing pro bono services, product donations, and institutional support including Canva, Nexxt, Techsoup, We Look, and Westwing

oncoguia.org.br
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details1 tier
1Free patient support services - all programs and services provided at no cost to patients and families
ModelFreemiumBilling cadenceMonthly
Notes

All cancer patient support services including hotline (0800 773 1666), WhatsApp support, email assistance, event participation, educational materials, and rights navigation are completely free. Services funded entirely by pharmaceutical industry sponsors and individual donations.

oncoguia.org.br
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 6 records shown
1Canal Ligue Câncer
Description

Free telephone helpline (0800 773 1666) providing personalized support and guidance for cancer patients

oncoguia.org.br
+5 more records
Core offering1 text field

Instituto Oncoguia provides free, evidence-based cancer patient education, support, and advocacy services through a multichannel platform spanning a web portal, toll-free 0800 hotline, WhatsApp, email, video, podcast, and in-person events. Its core offerings include cancer information across 60+ cancer types, patient rights navigation, clinical trial listings, a public policy monitoring dashboard, and a national patient support program (Programa Nacional de Apoio ao Paciente com Câncer) serving patients and families across Brazil.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Instituto Oncoguia operates primarily as a patient support organization rather than a software product company. Its core offering is a unified patient empowerment and information platform centered around the Portal Oncoguia website, which provides educational content about cancer, patient rights, and treatment information. The organization complements its web portal with complementary services including the Radar do Câncer data monitoring tool, Atlas CCC cancer care center locator, Pesquisa Clínica clinical trial panel, TV Oncoguia video content, Podcast Oncoguia audio series, and the Canal Ligue Câncer telephone support line (0800 773 1666). Key programs include the Plataforma Multicanal multi-channel patient support system, PAR patient empowerment program, and the Painel de Políticas Públicas public policy monitoring panel. The organization also produces educational brochures, organizes patient events, and conducts advocacy for cancer patient rights in Brazil.

Product and service10 records
1Portal Oncoguia
CategoryPatient Education Portal
Description

A comprehensive web portal providing evidence-based information, support resources, and patient rights guidance for cancer patients, families, and caregivers across Brazil, with content covering 60+ cancer types, treatments, and quality of life topics.

2Radar do Câncer
CategoryHealth Data Monitoring
Description

A monitoring tool that collects and analyzes cancer data from public health databases (DATASUS, INCA, Globocan) to track disease patterns, treatment access, and healthcare disparities across Brazil in support of public policy advocacy.

3Atlas CCC (Atlas dos Centros de Cuidados do Câncer)
CategoryHealthcare Facility Directory
Description

A geographic database mapping cancer care centers across Brazil to help patients locate treatment facilities.

4Pesquisa Clínica (Clinical Research Panel)
CategoryClinical Trial Information
Description

A panel providing information about open clinical trials for cancer patients in Brazil, facilitating access to experimental treatments.

5Plataforma Multicanal - Programa Nacional de Apoio ao Paciente com Câncer (PAP)
CategoryPatient Support Program
Description

A multichannel patient support platform offering personalized guidance on quality of life and patient rights through phone (0800 line), email, WhatsApp, and social media channels for cancer patients and families.

6Canal Ligue Câncer (0800 773 1666)
CategoryPatient Helpline
Description

A free, toll-free telephone helpline (0800 773 1666) providing personalized cancer-related guidance and support to patients and families, operating Monday to Friday 9AM-5:30PM.

7Painel de Políticas Públicas
CategoryPolicy Monitoring Dashboard
Description

A public policy monitoring dashboard tracking cancer-related legislation and healthcare policies in Brazil to support advocacy efforts.

8TV Oncoguia
CategoryEducational Video Content
Description

A video content library featuring interviews, educational videos, event recordings, and expert discussions on cancer topics for patient education and awareness.

9Podcast Oncoguia
CategoryEducational Podcast
Description

An audio podcast series discussing cancer-related topics for patient education and awareness.

10PAR (Paciente Ativo e Responsável)
CategoryPatient Empowerment Program
Description

A program empowering cancer patients to actively participate in their treatment decisions and healthcare management, rooted in the PAC (Paciente Ativo e Responsável) philosophy.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Global cancer coalition membership providing Instituto Oncoguia with international cancer control frameworks, global best practices, and collaborative opportunities with cancer organizations worldwide.

2IKCC (International Kidney Cancer Coalition)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Active membership in international kidney cancer coalition, participating in global initiatives and representing Brazilian kidney cancer patients in international advocacy efforts.

oncoguia.org.br
3World Ovarian Cancer Coalition
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Coalition membership supporting Instituto Oncoguia's participation in global ovarian cancer awareness and advocacy initiatives, aligning with global objectives for ovarian cancer care improvement.

oncoguia.org.br
4World Pancreatic Cancer Coalition
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Coalition membership enabling participation in global pancreatic cancer awareness campaigns and advocacy efforts to improve patient outcomes.

oncoguia.org.br
5Global Lung Cancer Coalition
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Coalition membership supporting lung cancer awareness and advocacy initiatives, contributing to global efforts to reduce lung cancer mortality.

oncoguia.org.br
6Global Melanoma Coalition
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Coalition membership for melanoma patient advocacy and awareness, participating in international melanoma awareness campaigns and best practice sharing.

oncoguia.org.br
7Global Colorectal Cancer Association
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Coalition membership supporting colorectal cancer awareness initiatives and advocacy efforts to improve early detection and patient outcomes.

oncoguia.org.br
8International Movement for Liver Cancer
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Coalition membership supporting liver cancer awareness and advocacy, participating in international efforts to improve liver cancer patient outcomes.

oncoguia.org.br
Strategic tierMinorTypeOthersAnnounced on2026-01-01
Description

Design platform partner providing pro bono access to design tools supporting Instituto Oncoguia's creation of cancer awareness materials and social media content.

Strategic tierMinorTypeOthersAnnounced on2026-01-01
Description

Technology donation program partner providing software and technology resources to support Instituto Oncoguia's digital operations and nonprofit mission.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1American Cancer Society
TypeDirect peer
Description

Largest US-based cancer patient advocacy and support organization, comparable in providing free cancer information, patient navigation, hotline support, and clinical trial information. While larger and US-focused, it operates on a similar nonprofit model with similar core services.

TypeDirect peer
Description

Global breast cancer advocacy organization providing patient education, support resources, and advocacy. Comparable in mission around cancer patient empowerment, information provision, and policy advocacy.

3FEMAMA (Federação Brasileira de Instituições Filantrópicas de Apoio à Saúde da Mama)
TypeDirect peer
Description

Brazilian federation supporting breast cancer patient organizations; comparable as a national-level cancer patient advocacy coalition operating in Brazil with similar member-network model and policy advocacy focus.

TypeDirect peer
Description

US-based pancreatic cancer advocacy organization providing patient services, clinical trial information, and policy advocacy. Comparable as a disease-specific cancer patient support organization with similar service portfolio.

TypeBroad incumbent
Description

Brazilian federal government's primary cancer control agency providing authoritative cancer information, statistics, and policy guidance. Comparable in providing cancer information to Brazilian patients but as a government entity rather than an independent NGO.

TypeOthers
Description

Global cancer coalition of which Oncoguia is a member; comparable as the umbrella network for cancer patient advocacy organizations, though operates at a coalition level rather than as a direct patient-facing service provider.

TypeRegional player
Description

Australia's leading cancer patient information, support, and advocacy organization. Comparable mission and service portfolio to Oncoguia but operating in a different geography (Australia vs Brazil).

TypeBroad incumbent
Description

UK-based cancer charity providing cancer information, support services, and funding research. Comparable in providing patient-facing cancer information and support, though more research-focused than Oncoguia.

TypeDirect peer
Description

Brazilian patient advocacy organization for blood cancers, providing patient support, education, and policy advocacy. Closely comparable in mission, geographic scope, and free-services model to Oncoguia.

TypeDirect peer
Description

US-based cancer survivor support organization providing patient navigation, emotional support, and resources to cancer patients and families. Comparable mission and patient empowerment approach, though with different geographic scope.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Instituto Oncoguia

Patient Advocacy and Cancer Support Servicesoncoguia.org.br

Instituto Oncoguia is a Brazilian non-profit NGO that provides free, evidence-based cancer information, patient support, advocacy, and clinical trial access to cancer patients, families, and caregivers across Brazil via a multichannel digital platform and national events.

What Instituto Oncoguia does

Instituto Oncoguia is a Brazilian non-profit civil association (associação civil sem fins lucrativos) founded in 2003 as Portal Oncoguia by psycho-oncologist Luciana Holtz de Camargo Barros in São Paulo, and officially incorporated as an NGO in 2009. The organization's mission is to combat cancer misinformation and provide evidence-based information, support, advocacy, and treatment access guidance to cancer patients, families, and caregivers across Brazil. It holds OSCIP certification and operates as a national reference institution for cancer patient information.

The organization delivers its services through a multichannel digital platform comprising the Portal Oncoguia web portal, free 0800 telephone hotline (Ligue Câncer), WhatsApp support, email guidance, TV Oncoguia YouTube channel, Podcast Oncoguia, and in-person patient events (OncoDebates, patient encounters). Core products include Radar do Câncer (a data monitoring platform tracking cancer statistics using SUS/DATASUS/INCA/Globocan data), Atlas CCC (geographic mapping of cancer care centers), Pesquisa Clínica (clinical trial information panel), and educational programs like PAR (Paciente Ativo e Responsável) and the Programa Nacional de Apoio ao Paciente com Câncer. Content covers 60+ cancer types and is verified by a Scientific Committee.

Instituto Oncoguia operates on a free-to-patient model with no charges for any services. Revenue is generated through pharmaceutical industry grants and sponsorships (from 20+ companies including Roche, AstraZeneca, Novartis, Pfizer, Bristol Myers Squibb Foundation, GSK, MSD, Lilly, and Johnson & Johnson), individual donations via the "Doe Agora" program, and pro bono institutional partnerships (Canva, Techsoup, Nexxt). The organization is a member of 14 international and national cancer coalitions including UICC, IKCC, World Ovarian Cancer Coalition, and Global Lung Cancer Coalition, and maintains editorial independence through a published Code of Conduct governing pharmaceutical relationships.

Instituto Oncoguia firmographics

Firmographics
Name
Instituto Oncoguia
Legal name
Instituto Oncoguia
Website
https://oncoguia.org.br
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
11–50 employees
Short description
Instituto Oncoguia is a Brazilian non-profit NGO that provides free, evidence-based cancer information, patient support, advocacy, and clinical trial access to cancer patients, families, and caregivers across Brazil via a multichannel digital platform and national events.
Ownership category
akta.pro rank

Instituto Oncoguia industry classification

Industry
Product category
Patient Advocacy and Cancer Support Services
NAICS
Individual and Family Services (6241), Other Individual and Family Services (62419), Educational Support Services (611710)
SIC
Services-Membership Organizations (8600), Services-Health Services (8000), Services-Educational Services (8200)
akta.pro industry
PRIMARYHLAJAKAN
Global Health Research, Evidence & Technical Assistance Organizations
Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health & Development Agencies (NGOs/Multilaterals)
SECONDARYHLALAFAD
Oncology Remote Symptom Monitoring & Care Navigation
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms

Keywords

  • Cancer patient education
  • Patient advocacy services
  • Clinical trial information
  • Patient rights navigation
  • Cancer helpline support

Where Instituto Oncoguia is headquartered

Location

Headquarters

HQ city
São Paulo
HQ country
Brazil
HQ region
Latin America

Offices1 record

Markets served

Instituto Oncoguia business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Pharmaceutical Industry Grants and Sponsorship: Instituto Oncoguia receives funding from pharmaceutical companies including Roche, AstraZeneca, Novartis, Pfizer, Bristol Myers Squibb Foundation, and 20+ other pharmaceutical companies for project financing, event sponsorship, and institutional support
  2. Individual Donations: Individual donations from supporters who contribute to the organization's mission through the 'Doe Agora' (Donate Now) program
  3. Institutional Partnerships: Partnerships with companies providing pro bono services, product donations, and institutional support including Canva, Nexxt, Techsoup, We Look, and Westwing

Pricing tiers

ModelBillingPrice
FreemiumMonthlyFree patient support services - all programs and services provided at no cost to patients and families

Distribution channels5 records

Marketing channels8 records

Instituto Oncoguia product offering

Product offering

Core offering

Instituto Oncoguia provides free, evidence-based cancer patient education, support, and advocacy services through a multichannel platform spanning a web portal, toll-free 0800 hotline, WhatsApp, email, video, podcast, and in-person events. Its core offerings include cancer information across 60+ cancer types, patient rights navigation, clinical trial listings, a public policy monitoring dashboard, and a national patient support program (Programa Nacional de Apoio ao Paciente com Câncer) serving patients and families across Brazil.

Product overview

Instituto Oncoguia operates primarily as a patient support organization rather than a software product company. Its core offering is a unified patient empowerment and information platform centered around the Portal Oncoguia website, which provides educational content about cancer, patient rights, and treatment information. The organization complements its web portal with complementary services including the Radar do Câncer data monitoring tool, Atlas CCC cancer care center locator, Pesquisa Clínica clinical trial panel, TV Oncoguia video content, Podcast Oncoguia audio series, and the Canal Ligue Câncer telephone support line (0800 773 1666). Key programs include the Plataforma Multicanal multi-channel patient support system, PAR patient empowerment program, and the Painel de Políticas Públicas public policy monitoring panel. The organization also produces educational brochures, organizes patient events, and conducts advocacy for cancer patient rights in Brazil.

Differentiator

Problem solved

Functional benefit

Brands

  • Canal Ligue Câncer: Free telephone helpline (0800 773 1666) providing personalized support and guidance for cancer patients
  • Radar do Câncer
  • Atlas CCC
  • Programa Nacional de Apoio ao Paciente com Câncer (PAP)
  • TV Oncoguia
  • PAR - Paciente Ativo e Responsável

Products and services

  • Portal Oncoguia A comprehensive web portal providing evidence-based information, support resources, and patient rights guidance for cancer patients, families, and caregivers across Brazil, with content covering 60+ cancer types, treatments, and quality of life topics.
  • Radar do Câncer A monitoring tool that collects and analyzes cancer data from public health databases (DATASUS, INCA, Globocan) to track disease patterns, treatment access, and healthcare disparities across Brazil in support of public policy advocacy.
  • Atlas CCC (Atlas dos Centros de Cuidados do Câncer) A geographic database mapping cancer care centers across Brazil to help patients locate treatment facilities.
  • Pesquisa Clínica (Clinical Research Panel) A panel providing information about open clinical trials for cancer patients in Brazil, facilitating access to experimental treatments.
  • Plataforma Multicanal - Programa Nacional de Apoio ao Paciente com Câncer (PAP) A multichannel patient support platform offering personalized guidance on quality of life and patient rights through phone (0800 line), email, WhatsApp, and social media channels for cancer patients and families.
  • Canal Ligue Câncer (0800 773 1666) A free, toll-free telephone helpline (0800 773 1666) providing personalized cancer-related guidance and support to patients and families, operating Monday to Friday 9AM-5:30PM.
  • Painel de Políticas Públicas A public policy monitoring dashboard tracking cancer-related legislation and healthcare policies in Brazil to support advocacy efforts.
  • TV Oncoguia A video content library featuring interviews, educational videos, event recordings, and expert discussions on cancer topics for patient education and awareness.
  • Podcast Oncoguia An audio podcast series discussing cancer-related topics for patient education and awareness.
  • PAR (Paciente Ativo e Responsável) A program empowering cancer patients to actively participate in their treatment decisions and healthcare management, rooted in the PAC (Paciente Ativo e Responsável) philosophy.

Companies that use Instituto Oncoguia

Customer profile

Segments4 records

Ideal customer profiles3 records

Instituto Oncoguia technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Instituto Oncoguia partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • UICC (Union for International Cancer Control)coreStrategic or Co-development Partner · 1 January 2026Global cancer coalition membership providing Instituto Oncoguia with international cancer control frameworks, global best practices, and collaborative opportunities with cancer organizations worldwide.
  • IKCC (International Kidney Cancer Coalition)coreStrategic or Co-development Partner · 1 January 2026Active membership in international kidney cancer coalition, participating in global initiatives and representing Brazilian kidney cancer patients in international advocacy efforts.
  • World Ovarian Cancer CoalitioncoreStrategic or Co-development Partner · 1 January 2026Coalition membership supporting Instituto Oncoguia's participation in global ovarian cancer awareness and advocacy initiatives, aligning with global objectives for ovarian cancer care improvement.
  • World Pancreatic Cancer CoalitioncoreStrategic or Co-development Partner · 1 January 2026Coalition membership enabling participation in global pancreatic cancer awareness campaigns and advocacy efforts to improve patient outcomes.
  • Global Lung Cancer CoalitioncoreStrategic or Co-development Partner · 1 January 2026Coalition membership supporting lung cancer awareness and advocacy initiatives, contributing to global efforts to reduce lung cancer mortality.
  • Global Melanoma CoalitioncoreStrategic or Co-development Partner · 1 January 2026Coalition membership for melanoma patient advocacy and awareness, participating in international melanoma awareness campaigns and best practice sharing.
  • Global Colorectal Cancer AssociationcoreStrategic or Co-development Partner · 1 January 2026Coalition membership supporting colorectal cancer awareness initiatives and advocacy efforts to improve early detection and patient outcomes.
  • International Movement for Liver CancercoreStrategic or Co-development Partner · 1 January 2026Coalition membership supporting liver cancer awareness and advocacy, participating in international efforts to improve liver cancer patient outcomes.
  • CanvaminorOthers · 1 January 2026Design platform partner providing pro bono access to design tools supporting Instituto Oncoguia's creation of cancer awareness materials and social media content.
  • TechsoupminorOthers · 1 January 2026Technology donation program partner providing software and technology resources to support Instituto Oncoguia's digital operations and nonprofit mission.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Instituto Oncoguia competitors and assessment

Company assessment

Direct peers

  • American Cancer Society: Largest US-based cancer patient advocacy and support organization, comparable in providing free cancer information, patient navigation, hotline support, and clinical trial information. While larger and US-focused, it operates on a similar nonprofit model with similar core services.
  • Susan G. Komen: Global breast cancer advocacy organization providing patient education, support resources, and advocacy. Comparable in mission around cancer patient empowerment, information provision, and policy advocacy.
  • FEMAMA (Federação Brasileira de Instituições Filantrópicas de Apoio à Saúde da Mama): Brazilian federation supporting breast cancer patient organizations; comparable as a national-level cancer patient advocacy coalition operating in Brazil with similar member-network model and policy advocacy focus.
  • Pancreatic Cancer Action Network: US-based pancreatic cancer advocacy organization providing patient services, clinical trial information, and policy advocacy. Comparable as a disease-specific cancer patient support organization with similar service portfolio.
  • ABRALE (Associação Brasileira de Linfoma e Leucemia): Brazilian patient advocacy organization for blood cancers, providing patient support, education, and policy advocacy. Closely comparable in mission, geographic scope, and free-services model to Oncoguia.
  • LIVESTRONG Foundation: US-based cancer survivor support organization providing patient navigation, emotional support, and resources to cancer patients and families. Comparable mission and patient empowerment approach, though with different geographic scope.

Broad incumbents

  • INCA (Instituto Nacional de Câncer José Alencar Gomes da Silva): Brazilian federal government's primary cancer control agency providing authoritative cancer information, statistics, and policy guidance. Comparable in providing cancer information to Brazilian patients but as a government entity rather than an independent NGO.
  • Cancer Research UK: UK-based cancer charity providing cancer information, support services, and funding research. Comparable in providing patient-facing cancer information and support, though more research-focused than Oncoguia.

Others

  • UICC (Union for International Cancer Control): Global cancer coalition of which Oncoguia is a member; comparable as the umbrella network for cancer patient advocacy organizations, though operates at a coalition level rather than as a direct patient-facing service provider.

Regional players

  • Cancer Council Australia: Australia's leading cancer patient information, support, and advocacy organization. Comparable mission and service portfolio to Oncoguia but operating in a different geography (Australia vs Brazil).

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

Instituto Oncoguia social profiles

Digital presence

Instituto Oncoguia compliance and trust

Trust signal

Compliance1 record

Instituto Oncoguia financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Instituto Oncoguia leadership team

Management profile

Number of profiles

Profiles7 records

Instituto Oncoguia funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Instituto Oncoguia M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Instituto Oncoguia

What does Instituto Oncoguia do?

Instituto Oncoguia provides free, evidence-based cancer patient education, support, and advocacy services through a multichannel platform spanning a web portal, toll-free 0800 hotline, WhatsApp, email, video, podcast, and in-person events. Its core offerings include cancer information across 60+ cancer types, patient rights navigation, clinical trial listings, a public policy monitoring dashboard, and a national patient support program (Programa Nacional de Apoio ao Paciente com Câncer) serving patients and families across Brazil.

Is Instituto Oncoguia a public or private company?

Instituto Oncoguia is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Instituto Oncoguia founded?

Instituto Oncoguia was founded in 2003. It employs 11 to 50 people.

Where is Instituto Oncoguia based?

Instituto Oncoguia is headquartered in São Paulo, Brazil, in the Latin America region.

How does Instituto Oncoguia make money?

Three revenue lines are on record. Pharmaceutical Industry Grants and Sponsorship is the primary driver. The others are individual Donations and institutional Partnerships.

Who are Instituto Oncoguia's main competitors?

Direct peers on record are American Cancer Society, Susan G. Komen, FEMAMA (Federação Brasileira de Instituições Filantrópicas de Apoio à Saúde da Mama), Pancreatic Cancer Action Network, ABRALE (Associação Brasileira de Linfoma e Leucemia) and LIVESTRONG Foundation. Broad incumbents are INCA (Instituto Nacional de Câncer José Alencar Gomes da Silva) and Cancer Research UK. UICC (Union for International Cancer Control) is listed as an others. Cancer Council Australia is listed as a regional player.

Does Instituto Oncoguia have an API?

No public API is recorded for Instituto Oncoguia.

What industry is Instituto Oncoguia in?

Instituto Oncoguia's product category is Patient Advocacy and Cancer Support Services. Its primary akta.pro industry code is HLAJAKAN, Global Health Research, Evidence & Technical Assistance Organizations, with a secondary code of HLALAFAD, Oncology Remote Symptom Monitoring & Care Navigation. Its NAICS code is 6241 and its SIC code is 8600.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireCampanha Sobre Viver conta histórias de superação de pacientes oncológicosA Bristol Myers Squibb-backed campaign called 'Sobre Viver' (About Living) has released nine episodes featuring real stories of lung cancer and melanoma patients to raise awareness about living with cancer and strengthen the patient-physician relationship. According to Brazil's National Cancer Institute (INCA), an estimated 625,000 new cancer cases were expected between 2020 and 2022 in the country, with non-melanoma skin cancer representing about 33% of all oncology diagnoses. The campaign, supported by Instituto Lado a Lado pela Vida, Instituto Oncoguia, and Instituto Vencer o Câncer, aims to promote early diagnosis and prevention, including sun protection strategies emphasized during the summer season.PR NewswireCampanha alerta sobre a importância da prática de atividade física como estratégia de prevenção ao câncer renalThe International Kidney Cancer Coalition (IKCC) launched its second consecutive #FALAI campaign in Brazil to raise awareness about physical activity as a prevention strategy for kidney cancer, citing studies showing regular exercise can reduce kidney cancer risk by up to 22%. The national campaign is led by Brazilian organizations Instituto Espaço de Vida and Instituto Oncoguia, with support from additional health institutes and pharmaceutical company Bristol Myers Squibb. Kidney cancer is among the 10 most common cancers worldwide, with approximately 6,270 new cases estimated in Brazil annually and a projected 22% global increase in cases by year-end.PR NewswireMovimento "Desafio de Fôlego" mobiliza artistas no combate ao câncer de pulmãoThe "Desafio de Fôlego" (Breath Challenge) awareness campaign was launched during Lung Cancer Awareness Month in Brazil, featuring Brazilian music artists who recorded duets with Ailton Ferreira, a sambista diagnosed with lung cancer in 2016 despite never smoking. The campaign is a partnership between Instituto Vencer o Câncer (IVOC), Instituto Oncoguia, and Pfizer, aiming to raise awareness about risk factors, symptoms, and early diagnosis of lung cancer. According to INCA, only 16% of lung cancer cases in Brazil are diagnosed at an early stage, with a five-year survival rate of 18%.PR NewswireNeste Outubro Rosa, ação educativa da Pfizer e do Oncoguia mobiliza metrô e 800 táxis de São PauloPfizer and the Oncoguia Institute launched an educational campaign in São Paulo during October to raise awareness about breast cancer myths. The initiative involves interactive quizzes on touch screens installed in 800 taxis and at metro stations, distributing educational leaflets to participants. This local effort is part of Pfizer's global 'Every Minute Counts' campaign conducted in partnership with ULACCAM.